The obtained results clearly showed a high positive correlation between GLCE expression and PSA level, Gleason score and TNM classification in the prostate tumors with increased GLCE expression, suggesting GLCE as a candidate molecular marker for advanced prostate cancer and potential target for new therapies. This evidence concerns the gene KLK3 and prostate cancer.